- Filed
- Mar 17, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 36.47M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2026 | 26.43M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 17.45M sh |
| Shares Diluted | Q3 2026 · Jan 31, 2025 | 17.45M sh |
| Operating Cash Flow | Q3 2026 · Jan 31, 2026 | $911.79K |
| Operating Cash Flow | Q3 2026 · Jan 31, 2025 | $6.39M |
| Long Term Debt | Q3 2026 · Jan 31, 2026 | $2.57M |
| Stockholders Equity | Q3 2026 · Jan 31, 2026 | $7.7M |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | $11.67M |
| Current Liabilities | Q3 2026 · Jan 31, 2026 | $18.79M |
| Current Liabilities | Q3 2026 · Apr 30, 2025 | $21.91M |
| Total Liabilities | Q3 2026 · Jan 31, 2026 | $64.53M |
| Total Liabilities | Q3 2026 · Apr 30, 2025 | $65.72M |
| Current Assets | Q3 2026 · Jan 31, 2026 | $12.57M |
| Current Assets | Q3 2026 · Apr 30, 2025 | $12.48M |
| Total Assets | Q3 2026 · Jan 31, 2026 | $72.09M |
| Total Assets | Q3 2026 · Apr 30, 2025 | $77.36M |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | −$0.21 |
| Eps Diluted | Q3 2026 · Jan 31, 2026 | −$0.53 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | $0.06 |
| Eps Diluted | Q3 2026 · Jan 31, 2025 | $0.08 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | −$0.21 |
| Eps Basic | Q3 2026 · Jan 31, 2026 | −$0.53 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | $0.06 |
| Eps Basic | Q3 2026 · Jan 31, 2025 | $0.08 |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $6M |
| Sga Expense | Q3 2026 · Jan 31, 2026 | $10.62M |
| Sga Expense restated | Q3 2026 · Jan 31, 2025 | $1.45M |
| Sga Expense restated | Q3 2026 · Jan 31, 2025 | $5.05M |
| Net Income | Q3 2026 · Jan 31, 2026 | −$5.21M |
| Net Income | Q3 2026 · Jan 31, 2026 | −$11.72M |
| Net Income | Q3 2026 · Jan 31, 2025 | $1.01M |
| Net Income | Q3 2026 · Jan 31, 2025 | $1.46M |
| Operating Income | Q3 2026 · Jan 31, 2026 | −$2.82M |
| Operating Income | Q3 2026 · Jan 31, 2026 | −$3.99M |
| Operating Income restated | Q3 2026 · Jan 31, 2025 | $1.19M |
| Operating Income restated | Q3 2026 · Jan 31, 2025 | $4.18M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $7.54M |
| Gross Profit | Q3 2026 · Jan 31, 2026 | $20.55M |
| Gross Profit restated | Q3 2026 · Jan 31, 2025 | $7.05M |
| Gross Profit restated | Q3 2026 · Jan 31, 2025 | $23.07M |
| Revenue | Q3 2026 · Jan 31, 2026 | $29.54M |
| Revenue | Q3 2026 · Jan 31, 2026 | $84.33M |
| Revenue restated | Q3 2026 · Jan 31, 2025 | $32.32M |
| Revenue restated | Q3 2026 · Jan 31, 2025 | $89.85M |